Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Monozygotic (MZ) twin pair discordance for childhood-onset Type 1 Diabetes (T1D) is ∼50%, implicating roles for genetic and non-genetic factors in the aetiology of this complex autoimmune disease. Although significant progress has been made in elucidating the genetics of T1D in recent years, the non-genetic component has remained poorly defined. We hypothesized that epigenetic variation could underlie some of the non-genetic component of T1D aetiology and, thus, performed an epigenome-wide association study (EWAS) for this disease. We generated genome-wide DNA methylation profiles of purified CD14+ monocytes (an immune effector cell type relevant to T1D pathogenesis) from 15 T1D-discordant MZ twin pairs. This identified 132 different CpG sites at which the direction of the intra-MZ pair DNA methylation difference significantly correlated with the diabetic state, i.e. T1D-associated methylation variable positions (T1D-MVPs). We confirmed these T1D-MVPs display statistically significant intra-MZ pair DNA methylation differences in the expected direction in an independent set of T1D-discordant MZ pairs (P = 0.035). Then, to establish the temporal origins of the T1D-MVPs, we generated two further genome-wide datasets and established that, when compared with controls, T1D-MVPs are enriched in singletons both before (P = 0.001) and at (P = 0.015) disease diagnosis, and also in singletons positive for diabetes-associated autoantibodies but disease-free even after 12 years follow-up (P = 0.0023). Combined, these results suggest that T1D-MVPs arise very early in the etiological process that leads to overt T1D. Our EWAS of T1D represents an important contribution toward understanding the etiological role of epigenetic variation in type 1 diabetes, and it is also the first systematic analysis of the temporal origins of disease-associated epigenetic variation for any human complex disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
DNA methylation profiling of human chromosomes 6, 20 and 22
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V. K., Attwood, J., Burger, M., Burton, J., Cox, T. V., Davies, R., Down, T. A., et al. (2006) · Nature Genetics · doi:10.1038/ng1909 · Cited by 1,348
Self-citationEpigenome-wide association studies for common human diseases
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3000 · Cited by 1,267
Self-citationGenetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265 · cited 1×
“For the initial genome-wide screen, we recruited 15 T1D– discordant MZ twin pairs (Table S1), selected according to the following criteria: (i) European origin; (ii) both co-twins available for study; (iii) diabetic twin had T1D diagnosed at ,20 years of age; (iv) neither twin was receiving drugs other than human insu…”
MethodInherited epigenetic variation — revisiting soft inheritance
Richards, E. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1834 · Cited by 1,192
Cited by
A data-driven approach to preprocessing Illumina 450K methylation array data
Pidsley, R., Y Wong, C. C., Volta, M., Lunnon, K., Mill, J., & Schalkwyk, L. C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-293 · Cited by 1,143
“However, for the investigation of subtle differences, such as those seen in common complex disorders such as schizophrenia [9,10] and diabetes [11],”
BackgroundAccounting for cellular heterogeneity is critical in epigenome-wide association studies
Jaffe, A. E., & Irizarry, R. A. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r31 · Cited by 1,067
“With many of these studies completed, few disease-associated loci have been reported outside of cancer [3], type 1 diabetes [4], and rheumatoid arthritis [5].”
BackgroundReinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlén, S.-E., Greco, D., Söderhäll, C., Scheynius, A., & Kere, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041361 · Cited by 1,035
Liu, Y., Aryee, M. J., Padyukov, L., Fallin, M. D., Hesselberg, E., Runarsson, A., Reinius, L., Acevedo, N., Taub, M., Ronninger, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2487 · Cited by 969
DNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
“…in DNA methylation that are found when comparing cancer and normal cells and which is probably due to the presence of an abnormal clone of cells, most of the absolute differences in DNA methylation that have been reported in non-cancer studies are modest in magnitude ranging from 0.13–11% [64–66].”
InfluentialTouleimat, N., & Tost, J. (2012) · Epigenomics · doi:10.2217/epi.12.21 · Cited by 507
Self-citationFactors underlying variable DNA methylation in a human community cohort
Lam, L. L., Emberly, E., Fraser, H. B., Neumann, S. M., Chen, E., Miller, G. E., & Kobor, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121249109 · Cited by 476
Hannon, E., Lunnon, K., Schalkwyk, L., & Mill, J. (2015) · Epigenetics · doi:10.1080/15592294.2015.1100786 · Cited by 455
From promises to practical strategies in epigenetic epidemiology
Mill, J., & Heijmans, B. T. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3405 · Cited by 354
BLUEPRINT to decode the epigenetic signature written in blood
Adams, D., Altucci, L., Antonarakis, S. E., Ballesteros, J., Beck, S., Bird, A., Bock, C., Boehm, B., Campo, E., Caricasole, A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2153 · Cited by 345
Self-citationGuidance for DNA methylation studies: statistical insights from the Illumina EPIC array
Mansell, G., Gorrie-Stone, T. J., Bao, Y., Kumari, M., Schalkwyk, L. S., Mill, J., & Hannon, E. (2019) · BMC Genomics · doi:10.1186/s12864-019-5761-7 · Cited by 340
Wong, C. C. Y., Meaburn, E. L., Ronald, A., Price, T. S., Jeffries, A. R., Schalkwyk, L. C., Plomin, R., & Mill, J. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.41 · Cited by 327
Age-associated epigenetic drift: implications, and a case of epigenetic thrift?
Teschendorff, A. E., West, J., & Beck, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt375 · Cited by 316
Self-citationDietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives
Milagro, F. I., Mansego, M. L., De Miguel, C., & Martínez, J. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.010 · Cited by 308
DNA Methylation Biomarkers: Cancer and Beyond
Mikeska, T., & Craig, J. (2014) · Genes · doi:10.3390/genes5030821 · Cited by 288
Making sense of the ageing methylome
Seale, K., Horvath, S., Teschendorff, A., Eynon, N., & Voisin, S. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00477-6 · Cited by 274
Gordon, L., Joo, J. E., Powell, J. E., Ollikainen, M., Novakovic, B., Li, X., Andronikos, R., Cruickshank, M. N., Conneely, K. N., Smith, A. K., et al. (2012) · Genome Research · doi:10.1101/gr.136598.111 · Cited by 272
DNA Methylation Map of Human Atherosclerosis
Zaina, S., Heyn, H., Carmona, F. J., Varol, N., Sayols, S., Condom, E., Ramírez-Ruz, J., Gomez, A., Gonçalves, I., Moran, S., et al. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000441 · Cited by 263
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Autoimmune diseases — connecting risk alleles with molecular traits of the immune system
Gutierrez-Arcelus, M., Rich, S. S., & Raychaudhuri, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.33 · Cited by 256
Lowe, R., Gemma, C., Beyan, H., Hawa, M. I., Bazeos, A., Leslie, R. D., Montpetit, A., Rakyan, V. K., & Ramagopalan, S. V. (2013) · Epigenetics · doi:10.4161/epi.24362 · Cited by 160
Self-citationOSCA: a tool for omic-data-based complex trait analysis
Zhang, F., Chen, W., Zhu, Z., Zhang, Q., Nabais, M. F., Qi, T., Deary, I. J., Wray, N. R., Visscher, P. M., McRae, A. F., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1718-z · Cited by 164
Current understandings of the pathogenesis of type 1 diabetes: genetics to environment
Giwa, A. M., Ahmed, R., Omidian, Z., Majety, N., Karakus, K. E., Omer, S. M., Donner, T., & Hamad, A. R. A. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.13 · Cited by 137
Zhao, J., Goldberg, J., Bremner, J. D., & Vaccarino, V. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182924cf4 · Cited by 122
DNA methylation studies using twins: what are they telling us?
Bell, J. T., & Spector, T. D. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-172 · Cited by 89
“Typically, studies have either used very small samples (n < 5) with high-resolution approaches such as bisulfite sequencing [28], or lower-resolution assays, such as Illumina27K, with modest sample sizes (n = 13 to 25) [4,23-25].”
BackgroundMethodEpigenetics in diabetic nephropathy, immunity and metabolism
Keating, S. T., van Diepen, J. A., Riksen, N. P., & El-Osta, A. (2018) · Diabetologia · doi:10.1007/s00125-017-4490-1 · Cited by 82
“studies of BMI [87] and type 1 diabetes [88].”
BackgroundPast, present and future of latent autoimmune diabetes in adults
Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3205 · Cited by 50
Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
Capobianco, E. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0155-4 · Cited by 39
“Epigenetics is acquiring relevance particularly from NGS applications [4].”
BackgroundGenetic and Environmental Impacts on DNA Methylation Levels in Twins
Yet, I., Tsai, P.-C., Castillo-Fernandez, J. E., Carnero-Montoro, E., & Bell, J. T. (2016) · Epigenomics · doi:10.2217/epi.15.90 · Cited by 36
Sun, Y. V. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0058-2 · Cited by 27
“Several epigenetic studies of MZ discordant twins have investigated DNA methylation profiles in relation to several human diseases such as diabetes [75], psychiatric disorders [76–79], cancer [80], and autoimmune diseases [81–83].”
Severe traumatic injury is associated with profound changes in DNA methylation
Eskesen, T. O., Almstrup, K., Elgaard, L., Arleth, T., Lassen, M. L., Creutzburg, A., Jensen, A. H., Breindahl, N., Dinesen, F., Vang, M., et al. (2024) · npj Genomic Medicine · doi:10.1038/s41525-024-00438-4 · Cited by 7
Metadata
- Authors
- Rakyan, V. K., Beyan, H., Down, T. A., Hawa, M. I., Maslau, S., Aden, D., Daunay, A., Busato, F., Mein, C. A., Manfras, B., Dias, K.-R. M., Bell, C. G., Tost, J., Boehm, B. O., Beck, S., & Leslie, R. D.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-29
- Volume
- 7
- Issue
- 9
- Pages
- e1002300
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2091503140
- Cited by
- 342
- References
- 37
- FWCI
- 20.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.